New hope for lung cancer patients: drug combo targets treatment resistance

NCT ID NCT07158489

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new combination of two drugs—gemcitabine (chemotherapy) and ivonescimab (a targeted therapy)—in people with advanced non-small cell lung cancer whose disease got worse after standard immunotherapy. The goal is to see if this combination can shrink tumors or stop them from growing. About 47 participants will receive the treatment, and researchers will measure how many respond. This is a phase 2 trial, meaning it's still early but could lead to better options for patients who have run out of effective treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NSCLC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Fribourgeois - Hôpital Cantonal

    Fribourg, Switzerland

  • Hôpitaux Universitaires de Genève

    Geneva, 1211, Switzerland

  • IOSI Ospedale Regionale di Bellinzona e Valli

    Bellinzona, 6500, Switzerland

  • Kantonsspital Baden

    Baden, 5404, Switzerland

  • Kantonsspital Graubuenden

    Chur, CH-7000, Switzerland

  • Kantonsspital Winterthur

    Winterthur, 8401, Switzerland

  • Universitätsspital Basel

    Basel, 4031, Switzerland